Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Powershares S&P Smallcap Low Vo | XSLV | Nov 21, 2024 | 50.21 | +1.29 |
PowerShares Variable Rate Investment Grade Portfolio | VRIG | Nov 21, 2024 | 25.08 | +0.02 |
PowerUp Acquisition A | PWUP | Nov 21, 2024 | 11.50 | 0.00 |
PowerUp Acquisition Unit | PWUPU | Nov 21, 2024 | 11.45 | +0.44 |
PPG Industries | PPG | Nov 21, 2024 | 122.68 | +1.15 |
PPL | PPL | Nov 21, 2024 | 34.85 | +1.69 |
PRA Group | PRAA | Nov 21, 2024 | 20.88 | -0.19 |
Prairie Operating | PROP | Nov 21, 2024 | 8.21 | +3.92 |
Praxis Precision Medicines | PRAX | Nov 21, 2024 | 73.06 | -0.84 |
Precigen | PGEN | Nov 21, 2024 | 0.90 | +7.91 |
Precipio | PRPO | Nov 21, 2024 | 6.00 | 0.00 |
Precision BioSciences | DTIL | Nov 21, 2024 | 6.50 | -9.47 |
Precision Drilling | PDS | Nov 21, 2024 | 66.13 | +1.52 |
Precision Optics | POCI | Nov 21, 2024 | 5.09 | -4.86 |
Predictive Oncology | POAI | Nov 21, 2024 | 0.69 | +5.58 |
Preferred Bank | PFBC | Nov 21, 2024 | 93.76 | +0.73 |
Preferred Portfolio Powershares | PGX | Nov 21, 2024 | 11.94 | +0.93 |
Preformed Line Products | PLPC | Nov 21, 2024 | 136.20 | +0.93 |
Prelude Therapeutics | PRLD | Nov 21, 2024 | 0.97 | +0.57 |
Premier A | PINC | Nov 21, 2024 | 22.42 | +0.85 |
Premier Financial | PFC | Nov 21, 2024 | 28.26 | +2.76 |
Premium Catering Holdings | PC | Nov 21, 2024 | 0.71 | 0.00 |
Prenetics Global A | PRE | Nov 21, 2024 | 4.42 | -6.36 |
Presidio Property Trust A | SQFT | Nov 21, 2024 | 0.49 | -2.30 |
Presidio Property Trust D Pref | SQFTP | Nov 21, 2024 | 14.40 | +0.73 |
Prestige Consumer Healthcare | PBH | Nov 21, 2024 | 84.14 | +1.78 |
Prestige Wealth | PWM | Nov 21, 2024 | 1.03 | +0.98 |
PriceSmart | PSMT | Nov 21, 2024 | 88.48 | +0.89 |
Prime Medicine | PRME | Nov 21, 2024 | 2.97 | -0.67 |
Primech Holdings | PMEC | Nov 21, 2024 | 0.75 | +5.63 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.